SCHEMBL9485643

SCHEMBL9485643

C=C(C)Cc1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.46
GFER P55789 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
MAOB P27338 4/20 0.41
MAOA P21397 2/20 0.39
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP19A1 P11511 4/20 0.38
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
FDPS P14324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015468 0.87 ALDH1A1 (0.38) ALDH1A1GFERTDP1CA2MAPT
SCHEMBL23892032 0.81 NOS1 (0.48) LOXL2NOS3NOS1NOS2
SCHEMBL23230257 0.80 LMNA (0.43) ALDH1A1TSHRMAPTMEN1KMT2A
SCHEMBL27727263 0.80 ALDH1A1 (0.50) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL10984806 0.78 NOS3 (0.43) ALDH1A1TSHRCA12CA1CA2
SCHEMBL1511861 0.78 LPL (0.44) ALDH1A1TSHRTDP1CA2HSD17B10
SCHEMBL465583 0.78 CA2 (0.50) ALDH1A1CYP3A4CA2ACHEHIF1A
SCHEMBL10339088 0.78 TDP1 (0.48) ALDH1A1CYP3A4GFERTSHRTDP1
SCHEMBL3899314 0.78 IDO1 (0.44) ALDH1A1TDP1KMT2AACHEALOX15
SCHEMBL9256936 0.78 ALDH1A1 (0.48) ALDH1A1CYP3A4GFERTSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663317-A1 ANTIBODIES TO QUETIAPINE HAPTENS AND USE THEREOF Janssen Pharmaceutica NV (BE) 2020-06-10 EP disclosed
EP-3453711-A1 LLP2A- BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT The Regents of the University of California (US) 2019-03-13 EP disclosed
EP-2888263-B1 HAPTENS OF RISPERIDONE AND PALIPERIDONE JANSSEN PHARMACEUTICA NV (BE) 2018-05-09 EP disclosed
WO-2009015179-A1 NOVEL COMPOUNDS AND METHODS OF USING THEM SYNDAX PHARMACEUTICALS, INC. (US) 2009-01-29 WO disclosed
US-5206342-A POLYMERIZATION OF CARBON MONOXIDE/NON CONJUGATED ALKENYL BENZENE SHELL OIL COMPANY (US) 1993-04-27 US disclosed